Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 61919-261

2 FDA label images from Direct_rx · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 61919-261). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Direct_rx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

261-15 (261 15)

261-15 (261 15)
Packaging label for CYCLOBENZAPRINE HCL 7.5 mg, 15 tablets. The label indicates this product is a generic for FLEXERIL and each tablet contains 7.5 mg cyclobenzaprine hydrochloride, USP. It is packaged and distributed by DIRECT RX, with lot sample and expiration details visible. The label also includes cautionary notes and dosage instructions to keep out of reach of children.*
FDA Label Image

61919-261-82 (61919 261 82)

61919-261-82 (61919 261 82)
Packaging label for Cyclobenzaprine HCl 7.5 mg tablets by Direct Rx. The label shows a count of 180 tablets and states each thin-coated tablet contains 7.5 mg of cyclobenzaprine hydrochloride, USP. It also notes that it is generic for Flexeril and includes lot number and expiration date details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.